Navigation Links
Q4500 Stress Test Monitor System

ProductsQ4500 Stress Test Monitor System
Company Quinton Cardiology Systems, Inc.
Item Q4500 Stress Test Monitor System
Features 
  • Design Your Display Format: The Q4500 gives you more flexibility in determining the appearance of the display during the stress test. Select from eight standard audio and/or visual alarms and pre-set them based on your patient's particular threshold levels.
  • Filters for Cleaner Traces: The Q4500 uses digital filters (patent pending) that dramatically reduce muscle artifact and baseline wander on your live ECG tracings.
  • Customize Your In-test Reports: The Q4500 lets you design your in-test reports in a variety of ways. Include and arrange any combination of data within two different report headers. Move these header blocks to the top or bottom of the page. Then ask yourself some questions.
  • Pre-Edit during Your Patient's Recovery: Now you can preview the final report and enter final report information while your patients are still in the recovery phase. That means you can start entering data immediately rather than waiting until the end of recovery to enter final report information. Enter your reason for ending the test, test impressions, and test conclusions. During this time the Q4500 continuously displays ECG waveforms in case any significant changes occur during your patient's recovery.
  • Customize Your Final Reports: Like many other systems, the Q4500 lets you include a summary page, interpretation, tabular report, graph page, average beat, and worst case summary for your final reports. But with the Q4500, you can also create your own personal formats. Select from over 30 different data templates; arrange them anywhere within the summary and interpretation headers.
    • Description Quinton stress test systems feature our internationally-acclaimed algorithm that is used by thousands worldwide. This algorithm has a proven record for reliability and accuracy in demanding clinical situations; and it's just one of several reasons why Quinton is a recognized market leader in the stress testing equipment business.
    Info Quinton Cardiology Systems, Inc.
    Customer Service: (800) 426-0337
    Web site: http://www.quinton.com/

    Related medicine products :

    1. Physiological Stress Loaded (P.S.L.) Stem
    2. Cortisol EIA Hypertension / Cardiac Evaluation, Cardiovascular 012-MDKCO1 Stress Hormones
    3. BioStress 2000
    4. ExTOL Exercise Stress Systems
    5. Quest Exercise Stress System
    6. Cambridge Heart CH2000 Stress-Test System
    7. X-Scribe II Stress Exercise System
    8. Q-Stress Cardiac Stress System
    9. Q-710 Stress Monitor and Resting ECG
    10. PCE-110 PC-Based Exercise Stress System
    11. PCE-210 PC-Based Exercise Stress System
    ...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
    ...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
    ...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
    ...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
    Medicine Products:
    (Date:12/2/2008)...SCO, Calif., Dec. 1 diaDexus, Inc....l for the automated format of the,PLAC Test for L... capable of,running on a wide range of clinical c...Food & Drug Administration (FDA) in December 2...f the CE Marked PLAC Test to Europe. , The ...
    (Date:12/2/2008)...e health differences between groups of immigrants ... are also great. The differences are seen for risk...ew report from the Norwegian Institute of Public H...ompared with each other and the ethnic Norwegian p... target health care better. , The five immigran...
    (Date:12/2/2008)... 2 Smile Reminder, the nation,s le..., unveiled the latest in industry,technology toda...igital tool,for capturing and distributing video ...atient testimonials onto popular platforms such as...w tool provides doctors with an effective,busines...
    (Date:12/2/2008)...for Tuesday, December 2, 2008 at 3 pm CST)--Radiol...l University of South Carolina in Charleston, S.C....ncer from exposure to radiation during computed to...tated and that new estimates are several times low...C researchers presented their findings at the ann...
    Breaking Medicine News(10 mins):Health News:diaDexus Receives CE Mark Certification for the PLAC(R) Test 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Radiological Society of North America research: Cancer risk from cardiac CT overstated 2
    ...cancer is the fourth leading cause of cancer death...o are usually affected // It is one of the most d...n until it has spread to other parts. Only about f...cancer patients survive the first five years after...
    ... comes in the way of the physical and mental growt...Tuesday stressing// on the need to "protect, prese...ting the first Global Youth Meet on Health in the ...lso a fundamental human right. While every citizen...
    ...e remedy of choice for treatment of influenza is c...ports of psychiatric// side effects, regulators s... change after series of cases of self-injury and m...y people who had been taking this drug Unfortunat...
    ...article published in the Lancet has brought to lig...blems for the Indian //community. With only 2.2per...he category of obese this clearly shows that the I.... It is estimated that 12 percent of the adult po...
    Other Medicine News:Health News:PM Stress the Need to Protect Health of Children 2Health News:Caution:Tamiflu ‘tames’ flu but psychiatric side effects now report 2
    (Date:12/2/2008)...A, Kan., Dec. 2 IBT Laboratories, ...earch laboratory specializing in immunology and al...tests to evaluate the response of patients whose ... immunodeficiency disorder, chemotherapy drugs, or...to prevent rejection of a transplant. The company ...
    (Date:12/1/2008)... , , CHICAGO, Dec. 2 /PRNewswire-USNewswir...mography (PEM), a new technique for imaging the br...a woman,s hormonal status, two factors that limit ...at detecting cancer. Results will be presented tod...ty of North America (RSNA). , , "The abili...
    (Date:12/1/2008)...Girl with Hypophosphatasia Treated With ENB-0040 a...innipeg , , MONTREAL, Dec. 1 /PRNewswire/ -...any focused on developing novel therapeutics for s...rst infant patient in its clinical program for hyp...nzyme Replacement Therapy (ERT) with ENB-0040 for ...
    (Date:12/1/2008)...nference Call Scheduled for Tuesday, December 9 at...ML -- , , SOUTH SAN FRANCISCO, Calif., Dec...icals, Inc. (Nasdaq: SNSS ), a biopharmaceutical...ization of new oncology therapeutics, today announ...e myeloid leukemia (AML) will be presented during ...
    Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Spheris Reports Third Quarter 2008 Results 29706 1Spheris Reports Third Quarter 2008 Results 29706 2Spheris Reports Third Quarter 2008 Results 29706 3Spheris Reports Third Quarter 2008 Results 29706 4Spheris Reports Third Quarter 2008 Results 29706 5Spheris Reports Third Quarter 2008 Results 29706 6Spheris Reports Third Quarter 2008 Results 29706 7Spheris Reports Third Quarter 2008 Results 29706 8Spheris Reports Third Quarter 2008 Results 29706 9Spheris Reports Third Quarter 2008 Results 29706 10Spheris Reports Third Quarter 2008 Results 29706 11MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 1MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 2MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 3MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 4MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 5MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results 29704 6Porter Novelli Named Agency of Record for Pharmavite 28R 29 LLC 29702 1Porter Novelli Named Agency of Record for Pharmavite 28R 29 LLC 29702 2Imagenetix Inc Reports Second Quarter and Six Month Results 9160 1Imagenetix Inc Reports Second Quarter and Six Month Results 9160 2Imagenetix Inc Reports Second Quarter and Six Month Results 9160 3Imagenetix Inc Reports Second Quarter and Six Month Results 9160 4
    ...GE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Alnylam...NAi therapeutics,company, announced today at the A...7 Annual Meeting that it will advance a,systemical...treatment of liver cancer and potentially other so... is an RNAi therapeutic that is,designed to target...
    ...IEJO, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - Avan...ositive top-line,results from the company,s Phase ...drug Zenvia(TM) (dextromethorphan,hydrobromide/qui...gma-1 agonist, in diabetic neuropathic pain., The ...ly diary,entries for the Pain Rating Scale as defi...
    Other Medicine Technology:Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 2Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 3Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 4Alnylam Announces Advancement of a New RNAi Therapeutic Development,Program for the Treatment of Liver Cancer 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 2Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 3Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 4Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 5Avanir Pharmaceuticals Announces Positive Results of Phase III,Study for Zenvia in Diabetic Neuropathic Pain 6